Strata Critical Medical, Inc. (SRTA) - Total Assets
Based on the latest financial reports, Strata Critical Medical, Inc. (SRTA) holds total assets worth $327.62 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check SRTA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Strata Critical Medical, Inc. - Total Assets Trend (2019–2025)
This chart illustrates how Strata Critical Medical, Inc.'s total assets have evolved over time, based on quarterly financial data. Explore investment intensity of Strata Critical Medical, Inc. to see how much of total assets are deployed in long-term investments.
Strata Critical Medical, Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
Strata Critical Medical, Inc.'s total assets of $327.62 Million consist of 38.8% current assets and 61.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.5% |
| Accounts Receivable | $39.96 Million | 12.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $47.50 Million | 14.6% |
| Goodwill | $88.21 Million | 27.1% |
Asset Composition Trend (2019–2025)
This chart illustrates how Strata Critical Medical, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SRTA stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Strata Critical Medical, Inc.'s current assets represent 38.8% of total assets in 2025, an increase from 0.5% in 2019.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2025, up from 0.5% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 27.1% of total assets.
Strata Critical Medical, Inc. Competitors by Total Assets
Key competitors of Strata Critical Medical, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Extendicare Inc
TO:EXE
|
Canada | CA$1.07 Billion |
|
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
|
China | CN¥8.17 Billion |
|
Sienna Senior Living Inc
TO:SIA
|
Canada | CA$2.35 Billion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL89.94 Billion |
|
Community Health Systems Inc
NYSE:CYH
|
USA | $13.18 Billion |
|
Hospital Mater Dei S.A
SA:MATD3
|
Brazil | R$4.40 Billion |
|
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
IS:LKMNH
|
Turkey | TL5.27 Billion |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
Strata Critical Medical, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.93 | 6.96 | 32.46 |
| Quick Ratio | 5.93 | 6.96 | 32.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $103.20 Million | $130.43 Million | $332.17 Million |
Strata Critical Medical, Inc. - Advanced Valuation Insights
This section examines the relationship between Strata Critical Medical, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.89 |
| Latest Market Cap to Assets Ratio | 1.54 |
| Asset Growth Rate (YoY) | 26.8% |
| Total Assets | $325.47 Million |
| Market Capitalization | $500.99 Million USD |
Valuation Analysis
Above Book Valuation: The market values Strata Critical Medical, Inc.'s assets above their book value (1.54x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Strata Critical Medical, Inc.'s assets grew by 26.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Strata Critical Medical, Inc. (2019–2025)
The table below shows the annual total assets of Strata Critical Medical, Inc. from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $325.47 Million | +26.80% |
| 2024-12-31 | $256.68 Million | -12.97% |
| 2023-12-31 | $294.94 Million | -9.26% |
| 2022-12-31 | $325.02 Million | -3.23% |
| 2021-12-31 | $335.88 Million | +1796.04% |
| 2020-12-31 | $17.71 Million | -93.62% |
| 2019-12-31 | $277.69 Million | -- |
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including … Read more